Combining the benefits of nanoparticle carriers and prodrugs can improve drug delivery efficiency. This Review discusses the design of lipid–prodrug nanomedicines with self-assembly properties for modulating drug release, reducing drug metabolism, and improving the pharmacokinetics and biodistribution for the treatment of severe diseases.
- Patrick Couvreur
- Sinda Lepetre-Mouelhi
- Maria J. Blanco-Prieto